Results 211 to 220 of about 30,114 (242)

The History of ANCA-associated Vasculitis

Rheumatic Disease Clinics of North America, 2010
An essential early step toward understanding vasculitis was recognition in 1948 of the differences between the small artery disease of polyarteritis, essentially sparing the glomerulus and lungs, and disease of glomerular vessels and small veins, often involving the lungs.
openaire   +2 more sources

Biomarkers in ANCA-Associated Vasculitis

Current Rheumatology Reports, 2013
Despite recent advances in the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), relapse remains common and patients often experience a variable clinical course after initial treatment. New biomarkers are needed to aid the management of these complex diseases.
Lindsay, Lally, Robert F, Spiera
openaire   +2 more sources

Pathology of ANCA-associated vasculitis

Clinical and Experimental Nephrology, 2012
According to the recent 2012 Chapel Hill Consensus Conference, ANCA-associated vasculitis is classified in the group of small vessel vasculitis. Pauci-immune necrotizing crescentic glomerulonephritis is the morphological hallmark of ANCA-associated vasculitis.
Ferrario, F, Vanzati, A, PAGNI, FABIO
openaire   +2 more sources

ANCA-associated vasculitis

Medicina Clínica (English Edition), 2023
Sandro, Herrera-Darias, Gilsy, Guillén-Chirinos, Juan Manuel, Gómez-Cerquera   +2 more
openaire   +2 more sources

Vasculitis for the internist: focus on ANCA-associated vasculitis

Internal and Emergency Medicine, 2017
Vasculitides comprise several diseases affecting vessels of different sizes, mainly arteries, but also capillaries and veins. Antineutrophil cytoplasm antibody-associated vasculitides (AAVs) belong to the systemic necrotizing small-vessel vasculitis group that comprises granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic ...
Benjamin, Chaigne, Loïc, Guillevin
openaire   +2 more sources

Autoantibodies in ANCA-associated Vasculitis

Rheumatic Disease Clinics of North America, 2010
Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides are systemic or more limited conditions characterized by necrotizing destruction of small and medium-sized vessels (eg, capillaries, venules, and arterioles). ANCAs are the most predominant autoantibodies in patients affected by vasculitis, but other autoantibodies may also occur ...
openaire   +2 more sources

ANCA associated pulmonary fibrosis: vasculitis or not vasculitis

Current Opinion in Pulmonary Medicine
Purpose of review The intersection of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and interstitial lung disease (ILD) represents a complex and increasingly recognized clinical challenge. This review aims to summarize current understanding, highlight diagnostic and therapeutic approaches, and identify ...
Codes-Méndez, H, Castillo, D, Moya-Alvarado, P, Giménez-Palleiro, A, Castellvi, I   +4 more
openaire   +3 more sources

Avacopan for the Treatment of ANCA-Associated Vasculitis

New England Journal of Medicine, 2021
David R W Jayne, Peter A Merkel, Thomas J Schall   +2 more
exaly  

The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis

Autoimmunity Reviews, 2021
Paul L A Van Daele, Marco W J Schreurs
exaly  

The involvement of NETs in ANCA-associated vasculitis

Frontiers in Immunology, 2023
Satoka Shiratori-Aso, Daigo Nakazawa
exaly